Health Trials

Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)

1

Review clinical trials related to Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency

This is a Phase 3, multicenter, 3-part study, with 2 randomized, double-blind, placebo-controlled parts and an open-label extension part, to evaluate the efficacy and safety of orally administered deucrictibant XR tablet for prophylaxis, and deucrictibant IR capsule for on-demand treatment of angioedema attacks in adult participants aged ≥ 18 years with AAE-C1INH.

Participants needed: 32
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Pharvaris Netherlands B.V.Updated: Jun 29, 2026Locations: 32
Eligibility criteria

Provision of written informed consent [+6]

Participation in a clinical study with any other investigational drug within the... [+11]

Read more